<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02106065</url>
  </required_header>
  <id_info>
    <org_study_id>E1240-W</org_study_id>
    <secondary_id>5IK2RX001240-02</secondary_id>
    <nct_id>NCT02106065</nct_id>
  </id_info>
  <brief_title>VA Cultivating Access to Resources, Education, and Skills for Dementia Caregivers</brief_title>
  <acronym>VACARES</acronym>
  <official_title>Dementia Caregiver Rehabilitation: Enhancing Veteran and Family-Centered Care</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to study the effects of an education and skill-building&#xD;
      intervention on family caregivers of Veterans with dementia.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      According to VA estimates, nearly 500,000 Veterans suffer from dementia. There is currently&#xD;
      no cure for dementia. Ultimately, dementia will have a large impact on quality of life in&#xD;
      Veterans and families, lead to expensive nursing home placement, and decrease life expectancy&#xD;
      for patients and family caregivers. The experience of high burden in a caregiver for a&#xD;
      Veteran with dementia increases the likelihood of permanent nursing home placement and can&#xD;
      separate Veterans from their families. To address the high burden of caring for a Veteran&#xD;
      with dementia, the investigators aim to study the effect of a rehabilitative intervention for&#xD;
      family caregivers of Veterans with dementia. This novel approach will use video technology&#xD;
      that can reach caregivers in rural areas who do not have easy access to major VA medical&#xD;
      centers.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 21, 2014</start_date>
  <completion_date type="Actual">September 30, 2019</completion_date>
  <primary_completion_date type="Actual">September 30, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Zarit Burden Inventory</measure>
    <time_frame>change from baseline at 6-months post intervention</time_frame>
    <description>The Zarit Burden Inventory is a self-report measure of caregiver burden. Higher scores on this assessment indicate greater levels of caregiver burden. Potential scores range from 0-88 with higher scores indicating more severe burden.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Center for Epidemiological Studies-Depression</measure>
    <time_frame>change from baseline at 6-months</time_frame>
    <description>change in caregiver depressive symptoms as measured by the Center for Epidemiological Studies-Depression (CES-D). Scores on the CES-D can range from 0-60 with higher scores suggesting greater depressive symptomatology.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Long-term Care Placement Status (Care Recipient)</measure>
    <time_frame>6-months post intervention</time_frame>
    <description>Based on caregiver interview, permanent placement of the care recipient in LTC will be ascertained</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in All-cause Mortality Status (Care Recipient)</measure>
    <time_frame>6-months post intervention</time_frame>
    <description>Based on caregiver interview, care recipient mortality status will be ascertained</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">32</enrollment>
  <condition>Dementia</condition>
  <condition>Caregivers</condition>
  <condition>Neurodegenerative Diseases</condition>
  <condition>Brain Diseases</condition>
  <arm_group>
    <arm_group_label>In-person Education and Skill-Building Rehabilitation (ESBR-i) Condition</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Education and Skill-Building Rehabilitation delivered in clinic</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Education and Skill-Building Rehabilitation over Video (ESBR-V) Condition</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Education and Skill-Building Rehabilitation delivered via video telehealth.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual Care Condition</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Usual Care plus supplemental paper education materials</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Education and Skill-Building Rehabilitation (ESBR)</intervention_name>
    <description>ESBR intervention consists of four, 90-minute sessions over a 4-6 week period. These four sessions are supplemented with booster sessions at 3 and 9 months post-intervention. Each group session (10 or fewer participants) is attended either in-clinic or via video telehealth technology within the VAPAHCS.</description>
    <arm_group_label>Education and Skill-Building Rehabilitation over Video (ESBR-V) Condition</arm_group_label>
    <arm_group_label>In-person Education and Skill-Building Rehabilitation (ESBR-i) Condition</arm_group_label>
    <other_name>ESBR</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Supplemental Education Materials</intervention_name>
    <description>Participants randomized to the Usual Care (UC) group will receive supplemental educational materials related to aging and dementia.</description>
    <arm_group_label>Usual Care Condition</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Inclusion criteria -- Participants must:&#xD;
&#xD;
          -  be adults (age 18)&#xD;
&#xD;
          -  report distress associated with being the primary caregiver for a Veteran family&#xD;
             member with all-cause dementia&#xD;
&#xD;
          -  reporting at least 2 of the following 6 items at baseline assessment: felt&#xD;
             overwhelmed, felt like they often needed to cry, were angry or frustrated, felt they&#xD;
             were cut off from family or friends, reported moderate to high levels of general&#xD;
             stress, or felt their health had declined&#xD;
&#xD;
          -  provide at least one hour of care (supervision or direct assistance) per week over the&#xD;
             past 3 months (other sources of caregiving for the Veteran with dementia can also be&#xD;
             utilized; e.g., respite, home health aide, other family members, etc.)&#xD;
&#xD;
          -  be proficient in spoken and written English&#xD;
&#xD;
          -  be capable of providing informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Exclusion criteria -- Potential participants will be screened and excluded for:&#xD;
&#xD;
          -  current or lifetime history of any psychiatric disorder with psychotic features&#xD;
&#xD;
          -  prominent suicidal or homicidal ideation&#xD;
&#xD;
          -  having met DSM-IV criteria for drug or alcohol abuse or dependence (except nicotine)&#xD;
             within the past six months&#xD;
&#xD;
          -  presence of alcohol intoxication (by breathalyzer) or alcohol withdrawal (by exam)&#xD;
             during study recruitment or participation&#xD;
&#xD;
          -  diagnosis of probable or possible dementia&#xD;
&#xD;
          -  a Telephone Cognitive Screen score of &lt; 20&#xD;
&#xD;
          -  participation in another caregiver intervention within the past year&#xD;
&#xD;
          -  lack of regular access to a telephone&#xD;
&#xD;
          -  illness that would prevent 24 months of study participation&#xD;
&#xD;
          -  planned transfer of care receiver to another caregiver or nursing home within 12&#xD;
             months&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Blake K Scanlon, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA Palo Alto Health Care System, Palo Alto, CA</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jennifer K Fairchild, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA Palo Alto Health Care System, Palo Alto, CA</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>VA Palo Alto Health Care System, Palo Alto, CA</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304-1290</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>March 27, 2014</study_first_submitted>
  <study_first_submitted_qc>April 2, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 7, 2014</study_first_posted>
  <results_first_submitted>December 10, 2020</results_first_submitted>
  <results_first_submitted_qc>July 20, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">August 13, 2021</results_first_posted>
  <last_update_submitted>July 20, 2021</last_update_submitted>
  <last_update_submitted_qc>July 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Dementia</keyword>
  <keyword>Caregivers</keyword>
  <keyword>Neurodegenerative Diseases</keyword>
  <keyword>Brain Diseases</keyword>
  <keyword>Cost of Illness</keyword>
  <keyword>Stress, Psychological</keyword>
  <keyword>Depression</keyword>
  <keyword>Vital Statistics</keyword>
  <keyword>Mortality</keyword>
  <keyword>Behavioral Symptoms</keyword>
  <keyword>Residential Facilities</keyword>
  <keyword>Emergency Medical Services</keyword>
  <keyword>Long-Term Care</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dementia</mesh_term>
    <mesh_term>Neurodegenerative Diseases</mesh_term>
    <mesh_term>Brain Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>June 3, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/65/NCT02106065/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>ESBR-i</title>
          <description>Education and Skill-Building Rehabilitation (in-clinic)&#xD;
Education and Skill-Building Rehabilitation (ESBR): ESBR intervention consists of four, 90-minute sessions over a 4-6 week period. These four sessions are supplemented with booster sessions at 3 and 9 months post-intervention. Each group session (10 or fewer participants) is attended either in-clinic or via video telehealth technology within the VAPAHCS.</description>
        </group>
        <group group_id="P2">
          <title>ESBR-v</title>
          <description>Education and Skill-Building Rehabilitation (over video telehealth)&#xD;
Education and Skill-Building Rehabilitation (ESBR): ESBR intervention consists of four, 90-minute sessions over a 4-6 week period. These four sessions are supplemented with booster sessions at 3 and 9 months post-intervention. Each group session (10 or fewer participants) is attended either in-clinic or via video telehealth technology within the VAPAHCS.</description>
        </group>
        <group group_id="P3">
          <title>Usual Care</title>
          <description>Usual Care plus supplemental paper education materials&#xD;
Supplemental Education Materials: Participants randomized to the Usual Care (UC) group will receive supplemental educational materials related to aging and dementia.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="11"/>
                <participants group_id="P3" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>6 Month Completion</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="8"/>
                <participants group_id="P3" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="8"/>
                <participants group_id="P3" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="10"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>ESBR-i</title>
          <description>Education and Skill-Building Rehabilitation (in-clinic)&#xD;
Education and Skill-Building Rehabilitation (ESBR): ESBR intervention consists of four, 90-minute sessions over a 4-6 week period. These four sessions are supplemented with booster sessions at 3 and 9 months post-intervention. Each group session (10 or fewer participants) is attended either in-clinic or via video telehealth technology within the VAPAHCS.</description>
        </group>
        <group group_id="B2">
          <title>ESBR-v</title>
          <description>Education and Skill-Building Rehabilitation (over video telehealth)&#xD;
Education and Skill-Building Rehabilitation (ESBR): ESBR intervention consists of four, 90-minute sessions over a 4-6 week period. These four sessions are supplemented with booster sessions at 3 and 9 months post-intervention. Each group session (10 or fewer participants) is attended either in-clinic or via video telehealth technology within the VAPAHCS.</description>
        </group>
        <group group_id="B3">
          <title>Usual Care</title>
          <description>Usual Care plus supplemental paper education materials&#xD;
Supplemental Education Materials: Participants randomized to the Usual Care (UC) group will receive supplemental educational materials related to aging and dementia.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="6"/>
            <count group_id="B2" value="11"/>
            <count group_id="B3" value="15"/>
            <count group_id="B4" value="32"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="71.0" spread="7.0"/>
                    <measurement group_id="B2" value="69.8" spread="10.7"/>
                    <measurement group_id="B3" value="65" spread="10.9"/>
                    <measurement group_id="B4" value="68.6" spread="9.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="14"/>
                    <measurement group_id="B4" value="22"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="10"/>
                    <measurement group_id="B4" value="20"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Zarit Burden Inventory</title>
          <description>The Zarit Burden Inventory is a self-report measure of caregiver burden. Scores range from 0-88 with higher scores indicating more severe burden.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="50.0" spread="5.2"/>
                    <measurement group_id="B2" value="30.6" spread="12.5"/>
                    <measurement group_id="B3" value="40.8" spread="12.0"/>
                    <measurement group_id="B4" value="40.47" spread="9.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Zarit Burden Inventory</title>
        <description>The Zarit Burden Inventory is a self-report measure of caregiver burden. Higher scores on this assessment indicate greater levels of caregiver burden. Potential scores range from 0-88 with higher scores indicating more severe burden.</description>
        <time_frame>change from baseline at 6-months post intervention</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ESBR-i</title>
            <description>Education and Skill-Building Rehabilitation (in-clinic)&#xD;
Education and Skill-Building Rehabilitation (ESBR): ESBR intervention consists of four, 90-minute sessions over a 4-6 week period. These four sessions are supplemented with booster sessions at 3 and 9 months post-intervention. Each group session (10 or fewer participants) is attended either in-clinic or via video telehealth technology within the VAPAHCS.</description>
          </group>
          <group group_id="O2">
            <title>ESBR-v</title>
            <description>Education and Skill-Building Rehabilitation (over video telehealth)&#xD;
Education and Skill-Building Rehabilitation (ESBR): ESBR intervention consists of four, 90-minute sessions over a 4-6 week period. These four sessions are supplemented with booster sessions at 3 and 9 months post-intervention. Each group session (10 or fewer participants) is attended either in-clinic or via video telehealth technology within the VAPAHCS.</description>
          </group>
          <group group_id="O3">
            <title>Usual Care</title>
            <description>Usual Care plus supplemental paper education materials&#xD;
Supplemental Education Materials: Participants randomized to the Usual Care (UC) group will receive supplemental educational materials related to aging and dementia.</description>
          </group>
        </group_list>
        <measure>
          <title>Zarit Burden Inventory</title>
          <description>The Zarit Burden Inventory is a self-report measure of caregiver burden. Higher scores on this assessment indicate greater levels of caregiver burden. Potential scores range from 0-88 with higher scores indicating more severe burden.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="8"/>
                <count group_id="O3" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.0" spread="2.6"/>
                    <measurement group_id="O2" value="-0.4" spread="5.0"/>
                    <measurement group_id="O3" value="1.6" spread="3.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Center for Epidemiological Studies-Depression</title>
        <description>change in caregiver depressive symptoms as measured by the Center for Epidemiological Studies-Depression (CES-D). Scores on the CES-D can range from 0-60 with higher scores suggesting greater depressive symptomatology.</description>
        <time_frame>change from baseline at 6-months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ESBR-i</title>
            <description>Education and Skill-Building Rehabilitation (in-clinic)&#xD;
Education and Skill-Building Rehabilitation (ESBR): ESBR intervention consists of four, 90-minute sessions over a 4-6 week period. These four sessions are supplemented with booster sessions at 3 and 9 months post-intervention. Each group session (10 or fewer participants) is attended either in-clinic or via video telehealth technology within the VAPAHCS.</description>
          </group>
          <group group_id="O2">
            <title>ESBR-v</title>
            <description>Education and Skill-Building Rehabilitation (over video telehealth)&#xD;
Education and Skill-Building Rehabilitation (ESBR): ESBR intervention consists of four, 90-minute sessions over a 4-6 week period. These four sessions are supplemented with booster sessions at 3 and 9 months post-intervention. Each group session (10 or fewer participants) is attended either in-clinic or via video telehealth technology within the VAPAHCS.</description>
          </group>
          <group group_id="O3">
            <title>Usual Care</title>
            <description>Usual Care plus supplemental paper education materials&#xD;
Supplemental Education Materials: Participants randomized to the Usual Care (UC) group will receive supplemental educational materials related to aging and dementia.</description>
          </group>
        </group_list>
        <measure>
          <title>Center for Epidemiological Studies-Depression</title>
          <description>change in caregiver depressive symptoms as measured by the Center for Epidemiological Studies-Depression (CES-D). Scores on the CES-D can range from 0-60 with higher scores suggesting greater depressive symptomatology.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="8"/>
                <count group_id="O3" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.0" spread="6.9"/>
                    <measurement group_id="O2" value="0.1" spread="3.3"/>
                    <measurement group_id="O3" value="-0.2" spread="5.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Long-term Care Placement Status (Care Recipient)</title>
        <description>Based on caregiver interview, permanent placement of the care recipient in LTC will be ascertained</description>
        <time_frame>6-months post intervention</time_frame>
        <population>This data was not collected thus is not reported here.</population>
        <group_list>
          <group group_id="O1">
            <title>ESBR-i</title>
            <description>Education and Skill-Building Rehabilitation (in-clinic)&#xD;
Education and Skill-Building Rehabilitation (ESBR): ESBR intervention consists of four, 90-minute sessions over a 4-6 week period. These four sessions are supplemented with booster sessions at 3 and 9 months post-intervention. Each group session (10 or fewer participants) is attended either in-clinic or via video telehealth technology within the VAPAHCS.</description>
          </group>
          <group group_id="O2">
            <title>ESBR-v</title>
            <description>Education and Skill-Building Rehabilitation (over video telehealth)&#xD;
Education and Skill-Building Rehabilitation (ESBR): ESBR intervention consists of four, 90-minute sessions over a 4-6 week period. These four sessions are supplemented with booster sessions at 3 and 9 months post-intervention. Each group session (10 or fewer participants) is attended either in-clinic or via video telehealth technology within the VAPAHCS.</description>
          </group>
          <group group_id="O3">
            <title>Usual Care</title>
            <description>Usual Care plus supplemental paper education materials&#xD;
Supplemental Education Materials: Participants randomized to the Usual Care (UC) group will receive supplemental educational materials related to aging and dementia.</description>
          </group>
        </group_list>
        <measure>
          <title>Long-term Care Placement Status (Care Recipient)</title>
          <description>Based on caregiver interview, permanent placement of the care recipient in LTC will be ascertained</description>
          <population>This data was not collected thus is not reported here.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in All-cause Mortality Status (Care Recipient)</title>
        <description>Based on caregiver interview, care recipient mortality status will be ascertained</description>
        <time_frame>6-months post intervention</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ESBR-i</title>
            <description>Education and Skill-Building Rehabilitation (in-clinic)&#xD;
Education and Skill-Building Rehabilitation (ESBR): ESBR intervention consists of four, 90-minute sessions over a 4-6 week period. These four sessions are supplemented with booster sessions at 3 and 9 months post-intervention. Each group session (10 or fewer participants) is attended either in-clinic or via video telehealth technology within the VAPAHCS.</description>
          </group>
          <group group_id="O2">
            <title>ESBR-v</title>
            <description>Education and Skill-Building Rehabilitation (over video telehealth)&#xD;
Education and Skill-Building Rehabilitation (ESBR): ESBR intervention consists of four, 90-minute sessions over a 4-6 week period. These four sessions are supplemented with booster sessions at 3 and 9 months post-intervention. Each group session (10 or fewer participants) is attended either in-clinic or via video telehealth technology within the VAPAHCS.</description>
          </group>
          <group group_id="O3">
            <title>Usual Care</title>
            <description>Usual Care plus supplemental paper education materials&#xD;
Supplemental Education Materials: Participants randomized to the Usual Care (UC) group will receive supplemental educational materials related to aging and dementia.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in All-cause Mortality Status (Care Recipient)</title>
          <description>Based on caregiver interview, care recipient mortality status will be ascertained</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="8"/>
                <count group_id="O3" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>24 Months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>ESBR-i</title>
          <description>Education and Skill-Building Rehabilitation (in-clinic)&#xD;
Education and Skill-Building Rehabilitation (ESBR): ESBR intervention consists of four, 90-minute sessions over a 4-6 week period. These four sessions are supplemented with booster sessions at 3 and 9 months post-intervention. Each group session (10 or fewer participants) is attended either in-clinic or via video telehealth technology within the VAPAHCS.</description>
        </group>
        <group group_id="E2">
          <title>ESBR-v</title>
          <description>Education and Skill-Building Rehabilitation (over video telehealth)&#xD;
Education and Skill-Building Rehabilitation (ESBR): ESBR intervention consists of four, 90-minute sessions over a 4-6 week period. These four sessions are supplemented with booster sessions at 3 and 9 months post-intervention. Each group session (10 or fewer participants) is attended either in-clinic or via video telehealth technology within the VAPAHCS.</description>
        </group>
        <group group_id="E3">
          <title>Usual Care</title>
          <description>Usual Care plus supplemental paper education materials&#xD;
Supplemental Education Materials: Participants randomized to the Usual Care (UC) group will receive supplemental educational materials related to aging and dementia.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Musculoskeletal injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Kaci Fairchild</name_or_title>
      <organization>VA Palo Alto Health Care System</organization>
      <phone>6504935000 ext 63432</phone>
      <email>jenniferkaci.fairchild@va.gov</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

